CFO Charles R. Carter to depart CERo Therapeutics; successor search underway

CERO THERAPEUTICS HOLDINGS, INC.

CFO Charles R. Carter informed Board he will leave on Sept 30, 2024 for a role at another public company.
Board has commenced a search for a new CFO; Carter will assist with transition for a brief period.
Carter's departure is effective Sept 30, 2024; no successor named yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Charles R. Carter

Chief Financial Officer

CERO · CERO THERAPEUTICS HOLDINGS, INC.

Effective: 2024-09-30
Filed: September 23, 2024, 7:59 PM ET

On September 17, 2024, the Chief Financial Officer of CERo Therapeutics Holdings, Inc. (the “ Company ”), Charles R. Carter, informed the Board of Directors of the Company (the “ Board ”) that he expects to accept a new position with another publicly-traded company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Charles R. Carter resigned as Chief Financial Officer at CERO THERAPEUTICS HOLDINGS, INC..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On September 17, 2024, the Chief Financial Officer of CERo Therapeutics Holdings, Inc. (the “ Company ”), Charles R. Carter, informed the Board of Directors of the Company (the “ Board ”) that he expects to accept a new position with another publicly-traded company.

View on SEC.gov

CERO THERAPEUTICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-081023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.